A major scientific advance in protein modeling developed by Microsoft Research AI for Science, has been published in Science.

A new study published in Cell has unveiled a first-of-a-kind optogenetic screening platform, developed by scientists at Integrated Biosciences, a biotechnology company integrating optogenetics, ...

Pharmaceutical major Wockhardt Ltd. is going to shift its focus to drug discovery and biologics after exiting the US generics ...

A new drug targets RAS-PI3Kα pathways without harmful side effects. It was developed using high-performance computing and AI.

WEHI has formed a partnership with the Parkinson's Research Foundation with one clear goal: to intensify the search for drug treatments to stop ...

Microsoft's CEO, Satya Nadella, has announced BioEmu-1, a new AI system designed to accelerate drug discovery by decoding ...

New drug discovery is a critical step for improving patients' lives. First, researchers must identify molecules in the body's cells that help drive disease, as these are potential targets for new ...

Drug discovery startup Synfini Inc. said today it has closed on an $8.9 million expansion funding round led by JSL Health ...

Barriers To Finding New Targets And Drugs. In drug discovery, scientists comb through what’s known as “omics” data—data related to the human genome, including DNA and RNA.

New tool to accelerate drug discovery Simpler, less-expensive method using bioluminescence shines light on real-time cellular traffic Date: March 22, 2022 ...

Chemists develop a new drug discovery strategy for 'undruggable' drug targets. ScienceDaily . Retrieved June 2, 2025 from www.sciencedaily.com / releases / 2020 / 12 / 201228095422.htm ...

Insilico Medicine recently announced that its new AI-designed drug for COVID-19 has entered Phase I clinical trials. If approved, it would become an alternative to the current antiviral medications.